DIANE HAWKINS: Open Payments
NPI 1851406383 · BRISTOL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 14 payments from 5 companies in 2025. Trend: 2023 $29 · 2024 $311 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $201 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: LYBALVI, ARISTADA, COBENFY, INGREZZA, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
